• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The role of the liver in serum-induced hypercoagulability.肝脏在血清诱导的高凝状态中的作用。
J Clin Invest. 1966 Feb;45(2):256-63. doi: 10.1172/JCI105338.
2
ACTIVATION PRODUCT, FACTOR IX, SERUM THROMBOTIC ACCELERATOR ACTIVITY, AND SERUM-INDUCED THROMBOSIS.激活产物、凝血因子IX、血清促凝活性和血清诱导的血栓形成
J Clin Invest. 1964 Feb;43(2):160-6. doi: 10.1172/JCI104900.
3
STASIS THROMBI INDUCED BY BACTERIAL ENDOTOXIN.细菌内毒素诱导的淤积性血栓
Circ Res. 1964 Jun;14:486-93. doi: 10.1161/01.res.14.6.486.
4
[Clinical and experimental studies on the contact factor. II. Experimental studies on the thrombotic activity of activation product].[接触因子的临床与实验研究。II. 激活产物血栓形成活性的实验研究]
Nihon Ketsueki Gakkai Zasshi. 1968 Dec;31(7):1155-64.
5
Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis.慢性非肝硬化性门静脉血栓形成患者的高凝状态。
Clin Gastroenterol Hepatol. 2012 Jan;10(1):72-8. doi: 10.1016/j.cgh.2011.09.010. Epub 2011 Sep 23.
6
[Technic of liver perfusion].[肝脏灌注技术]
Z Exp Chir. 1971;4(4):224-7.
7
Withering heights--high factor levels a new thrombotic risk?
CAP Today. 2000 Nov;14(11):1, 26-8, 30 passim.
8
Further studies on the activation of factor IX by activated factor XI.关于活化因子XI对因子IX激活作用的进一步研究。
Thromb Diath Haemorrh Suppl. 1965;17:15-22.
9
Coagulation abnormalities in cirrhotic patients with portal vein thrombosis.门静脉血栓形成的肝硬化患者的凝血异常
Clin Lab. 2007;53(9-12):583-9.
10
Thrombogenicity of factor IX complex: in vivo investigation.凝血因子IX复合物的血栓形成性：体内研究
Dev Biol Stand. 1987;67:149-55.

引用本文的文献

1
Factor VIIa binding and internalization in hepatocytes.肝细胞中凝血因子VIIa的结合与内化
J Thromb Haemost. 2005 Oct;3(10):2264-73. doi: 10.1111/j.1538-7836.2005.01542.x.
2
Metabolism of fibrinogen in cirrhosis of the liver.肝脏肝硬化中纤维蛋白原的代谢
J Clin Invest. 1971 Aug;50(8):1690-701. doi: 10.1172/JCI106658.
3
Local and systemic factors in the pathogenesis of thrombosis.血栓形成发病机制中的局部和全身因素。
Calif Med. 1970 Mar;112(3):31-40.
4
Progress in disseminated intravascular coagulation.弥散性血管内凝血的进展
Calif Med. 1969 Sep;111(3):186-98 contd.
5
[Proceedings: Physiology of the coagulation mechanism (author's transl)].[会议论文：凝血机制的生理学（作者译）]
Langenbecks Arch Chir. 1973;334:763-9. doi: 10.1007/BF01286642.
6
Impaired coagulation in the bleeding of chronic liver disease.慢性肝病出血时的凝血功能障碍。
J R Coll Physicians Lond. 1973 Oct;8(1):79-86.
7
[Endogenous inhibitors of fibrinolytic activity in liver cirrhosis (author's transl)].肝硬化中纤维蛋白溶解活性的内源性抑制剂（作者译）
Klin Wochenschr. 1973 Dec 1;51(23):1170-2. doi: 10.1007/BF01468567.
8
Intravascular fibrin deposits, hepatic infarcts and thrombocytopenia in parent/F mouse chimeras with host-versus-graft syndrome.患有宿主抗移植物综合征的亲代/ F小鼠嵌合体中的血管内纤维蛋白沉积、肝梗死和血小板减少症。
Am J Pathol. 1975 Apr;79(1):131-46.
9
Fulminant hepatic failure secondary to congestive heart failure.继发于充血性心力衰竭的暴发性肝衰竭。
Am J Dig Dis. 1976 Oct;21(10):895-900. doi: 10.1007/BF01072084.
10
Dysfibrinogenemia associated with liver disease.与肝脏疾病相关的异常纤维蛋白原血症
J Clin Invest. 1977 Jul;60(1):89-95. doi: 10.1172/JCI108773.

本文引用的文献

1
Studies in intravascular coagulation. III. The pathogenesis of serum-induced venous thrombosis.血管内凝血研究。III. 血清诱导静脉血栓形成的发病机制。
J Clin Invest. 1955 Apr;34(4):647-51. doi: 10.1172/JCI103114.
2
ROLES OF SURFACE FACTOR AND A PLASMA INHIBITORY ACTIVITY (ANTI-SF) DURING EXPERIMENTAL THROMBOSIS IN RABBITS.表面因子和血浆抑制活性（抗表面因子）在兔实验性血栓形成过程中的作用
Thromb Diath Haemorrh. 1964 Dec 31;12:489-504.
3
ACTIVATION PRODUCT, FACTOR IX, SERUM THROMBOTIC ACCELERATOR ACTIVITY, AND SERUM-INDUCED THROMBOSIS.激活产物、凝血因子IX、血清促凝活性和血清诱导的血栓形成
J Clin Invest. 1964 Feb;43(2):160-6. doi: 10.1172/JCI104900.
4
The relation of factors XII, XI, and IX to hypercoagulable states.凝血因子XII、XI和IX与高凝状态的关系。
Thromb Diath Haemorrh. 1963 Apr 15;9:90-101.
5
Studies on the in vivo behavior of blood coagulation product I in rats.大鼠体内凝血产物I的行为研究。
Thromb Diath Haemorrh. 1962 Nov 15;8:276-85.
6
Serum-induced thrombosis. Studies of its induction, and evolution under controlled conditions in vivo.
Circulation. 1959 Nov;20:864-74. doi: 10.1161/01.cir.20.5.864.
7
Biologic assay of a thrombosis-inducing activity in human serum.
J Appl Physiol. 1959 Nov;14:943-6. doi: 10.1152/jappl.1959.14.6.943.
8
Effect of intravenous blood thromboplastin intermediates on clotting in rats.静脉注射血液凝血活酶中间体对大鼠凝血的影响。
Am J Physiol. 1958 Oct;195(1):77-80. doi: 10.1152/ajplegacy.1958.195.1.77.
9
A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases.一种测定血清谷草转氨酶和谷丙转氨酶的比色法。
Am J Clin Pathol. 1957 Jul;28(1):56-63. doi: 10.1093/ajcp/28.1.56.

The role of the liver in serum-induced hypercoagulability.

作者信息

Deykin D

出版信息

J Clin Invest. 1966 Feb;45(2):256-63. doi: 10.1172/JCI105338.

DOI:10.1172/JCI105338
PMID:5901509
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC292690/
Abstract
摘要